Le Lézard
Classified in: Science and technology
Subject: PDT

AxonDAO Goes Multichain with Arbitrum


NEW YORK, April 17, 2024 /PRNewswire/ -- AxonDAO is expanding the accessibility of its native governance token by taking it multi-chain, introducing a liquidity pool featuring Wrapped $AXGT on the Arbitrum blockchain. This strategic initiative, set to launch on Wednesday, April 17th at 8 AM EST, aims to streamline transactions and reduce operational costs for $AXGT holders. The move will significantly boost liquidity and foster greater engagement within the global decentralized science (DeSci) ecosystem. This development marks a key milestone in AxonDAO's ongoing efforts to integrate innovative blockchain solutions that revolutionize the future of scientific research. 

AxonDAO is expanding the accessibility of its native governance token on Arbitrum.

AxonDAO's strategic deployment on Arbitrum marks a significant advancement for the Arbitrum community and DeSci as a whole. By integrating with Arbitrum, AxonDAO will capitalize on its high throughput, low cost, and Ethereum compatibility, enhancing the scalability, efficiency, and accessibility of decentralized scientific research without compromising on security or decentralization.

"Establishing a presence on Arbitrum represents a transformative step for AxonDAO and the broader scientific community," said AxonDAO CEO Christopher Crecelius. "This move will enable us to make decentralized scientific research more transparent, efficient, and cost-effective. It aligns perfectly with our mission to democratize science through blockchain technology."

Building on the momentum of its inaugural Layer 2 deployment, AxonDAO has promised to announce the upcoming launch of a second Layer 2 platform next month. Further details will be shared during AxonDAO's Twitter X AMAs in the weeks ahead.

In the meantime, AxonDAO invites all scientific researchers, DeSci enthusiasts, and $AXGT holders to give their continued support to the development of a more inclusive and autonomous future in scientific research.

About AxonDAO

AxonDAO is a decentralized autonomous organization dedicated to funding scientific research so that it may be conducted independently and transparently, adhering to the highest ethical standards.

Driven by the collective wisdom and participation of its community, AxonDAO's platform represents a paradigm shift in how health data and scientific research are approached, turning individual health data into a valuable asset that benefits both the data provider and the broader scientific community.

For more information about AxonDAO and its activities on Arbitrum, please visit www.AxonDAO.io or contact [email protected].

SOURCE AxonDAO


These press releases may also interest you

at 03:00
The Wall Street Technology Association (WSTA®), a not-for-profit organization that provides financial technology and business professionals a forum to learn from and connect with...

at 03:00
New York Restaurateurs and entrepreneurs are switching to the latest ezPaycheck software as a more favorable alternative to processing paychecks and tips for multiple locations. Halfpricesoft.com confirms that there are no hidden fees or monthly...

at 03:00
Circular Edge, a global business advisory and consulting services provider specializing in Enterprise Resource Planning (ERP) solutions and support across Oracle JD Edwards, Cloud Infrastructure, Oracle Fusion Cloud Enterprise Performance...

at 02:32
Over the last three to four years, the driverless robotaxi industry has begun to flourish. Driverless services are coming online in multiple cities across the US and China. IDTechEx's recent report, "Future Automotive Technologies 2024-2034:...

at 02:05
Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) today announced the launch of a digital out-of-home media campaign inviting three million people in London to see and understand how virtual worlds are impacting real life in areas such as...

at 02:05
Epsilogen, a global leader in the development of immunoglobulin E (IgE) antibodies to treat cancer, today announces the appointments of Ashley Nagle as Chief Business Officer (CBO) and Peter Finan, currently a Non-Executive Director, as Non-Executive...



News published on and distributed by: